Ostergaard S, Munksgaard L, Hammer T, Nielsen T, Pedersen M, Gjerdrum L
Ann Hematol. 2025; .
PMID: 39853347
DOI: 10.1007/s00277-025-06194-4.
Xiao F, Cai Y, Fang J, Shen Y, Yu B, Zhang Y
Front Genet. 2023; 14:1228372.
PMID: 38028606
PMC: 10657880.
DOI: 10.3389/fgene.2023.1228372.
Berendsen M, van Bladel D, Hesius E, Berganza Irusquieta C, Rijntjes J, Spriel A
Hemasphere. 2023; 7(11):e976.
PMID: 37928625
PMC: 10621888.
DOI: 10.1097/HS9.0000000000000976.
Zhu J, Zhu X, Xie F, Ding Y, Lu H, Dong Y
Pathol Oncol Res. 2023; 29:1611070.
PMID: 37151353
PMC: 10154527.
DOI: 10.3389/pore.2023.1611070.
Wang J, Yan H, Tian S, Qin L, Ma Y
Quant Imaging Med Surg. 2022; 12(1):862-867.
PMID: 34993124
PMC: 8666792.
DOI: 10.21037/qims-20-1319.
Histologic Transformation in an Untreated Waldenstrom's Macroglobulinemia After 14 Years: Case Report and Review of the Literature.
Elimimian E, Bilani N, Diacovo M, Sirvaitis S, Fu C
J Hematol. 2021; 10(1):25-29.
PMID: 33643507
PMC: 7891909.
DOI: 10.14740/jh767.
Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?.
Boiza-Sanchez M, Manso R, Balague O, Chamizo C, Askari E, Salgado R
PLoS One. 2020; 15(11):e0241634.
PMID: 33180881
PMC: 7661053.
DOI: 10.1371/journal.pone.0241634.
A prognostic index predicting survival in transformed Waldenström macroglobulinemia.
Durot E, Kanagaratnam L, Zanwar S, Kastritis E, DSa S, Garcia-Sanz R
Haematologica. 2020; 106(11):2940-2946.
PMID: 33179472
PMC: 8561274.
DOI: 10.3324/haematol.2020.262899.
[Clonal-related transformation from Waldenström macroglobulinemia to diffuse large B cell lymphoma during the treatment of ibrutinib: a case report and literature review].
Xia Y, Zhu H, Wang L, Chen R, Chen W, Ding C
Zhonghua Xue Ye Xue Za Zhi. 2020; 41(9):770-772.
PMID: 33113611
PMC: 7595864.
DOI: 10.3760/cma.j.issn.0253-2727.2020.09.012.
